Rolny; Vinzent

Patent Applications and Registrations

Patent applications and USPTO patent grants for Rolny; Vinzent.The latest application filed is for "igfbp7 ratio for hfpef".

Company Profile

5.2.14

Rolny; Vinzent - Munich DE
ROLNY; Vinzent - Penzberg DE
Rolny; Vinzent - Muenchen DE
Rolny; Vinzent - Munchen DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods of identifying an individual to be treated by chemotherapy based on cytokeratin-19 fragments (CYFRA 21-1) and carcinoembryonic antigen (CEA) marker molecules and related uses Grant 11,402,381 - Krause , et al. August 2, 2	2022-08-02
IGFBP7 RATIO FOR HFpEF App 20220229075 - HABBEN; Kai ; et al.	2022-07-21
Circulating Fgfbp-1 (fibroblast Growth Factor-binding Pro-tein 1) In The Assessment Of Atrial Fibrillation And For The Prediction Of Stroke App 20210239712 - Kastner; Peter ; et al.	2021-08-05
Circulating Spon-1 (spondin-1) In The Assessment Of Atrial Fibrillation App 20210215716 - Kastner; Peter ; et al.	2021-07-15
Thymidine Kinase (tk-1) In Prognostic Indices For Dlbcl App 20210199659 - Rolny; Vinzent ; et al.	2021-07-01
Circulating Tfpi-2 (tissue Factor Pathway Inhibitor 2) In The Assessment Of Atrial Fibrillation And Anticoagulation Therapy App 20210181211 - Kastner; Peter ; et al.	2021-06-17
Ces-2 (carboxylesterase-2) For The Assessment Of Afib Related Stroke App 20210172962 - Dietrich; Manuel ; et al.	2021-06-10
Circulating Dkk3 (dickkopf-related Protein 3) In The Assessment Of Atrial Fibrillation App 20210156875 - Karl; Johann ; et al.	2021-05-27
Biomarkers For Risk Prediction Of Mortality App 20200371114 - Latini; Roberto ; et al.	2020-11-26
Circulating Angiopoietin-2 (ang-2) And Insulin-like Growth Factor-binding Protein 7 (igfbp7) For The Prediction Of Stroke App 20200300869 - Wienhues-Thelen; Ursula-Henrike ; et al.	2020-09-24
Fatty Acid Binding Protein 3 For The Assessment Of Atrial Fibrillation (af) App 20200116708 - Karl; Johann ; et al.	2020-04-16
Biomarkers for risk prediction of mortality Grant 10,557,858 - Latini , et al. Feb	2020-02-11
Circulating Esm-1 (endocan) In The Assessment Of Atrial Fibrillation And/or Stroke App 20190162737 - Karl; Johann ; et al.	2019-05-30
Methods Of Detecting A Relapse Of A Lung Adenocarcinoma Based On Marker Human Epididymis Protein 4 (he4) And Related Uses App 20180292410 - Dayyani; Farshid ; et al.	2018-10-11
Biomarkers And Methods Of Prediction App 20170322225 - Dieterle; Thomas ; et al.	2017-11-09
Biomarkers For Risk Prediction Of Mortality App 20170227552 - Latini; Roberto ; et al.	2017-08-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.